Skip to main content
. 2019 Sep 27;50(11):3004–3012. doi: 10.1161/STROKEAHA.119.026545

Figure 4.

Figure 4.

Effects of genetically lower factor XI (FXI) levels in high-risk subgroups in the UK Biobank. Hazard ratios (HR) of subgroup analyses of relevant risk factors for (A) ischemic stroke and (B) venous thromboembolism and the FXI genetic score. We observed no significant interactions between any risk factors and the FXI genetic score. C, Survival analysis of differences in ischemic stroke rate for participants with the strongest observed genetic effect on FXI (red) and participants with no genetic effect (black) stratified by atrial fibrillation (AF) presence. While we observed similar relative risk reduction conferred by genetically lower FXI in the presence (dashed) and absence (solid) of AF, it can be seen that the absolute risk reduction in the AF subgroup is markedly higher.